Abstract
Cutaneous reactions from targeted biologics are increasingly common. We describe a case of a cutaneous lichenoid drug eruption from the RANK inhibitor denosumab and a previously unreported lymphohistiocytic reaction pattern. The clinical and histopathological details of this case will aid in recognition, diagnosis, and treatment of drug rashes from denosumab.
Original language | English (US) |
---|---|
Pages (from-to) | 156-158 |
Number of pages | 3 |
Journal | Journal of Cutaneous Pathology |
Volume | 45 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2018 |
Keywords
- cutaneous hypersensitivity
- dermatopathology
- drug eruption
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Histology
- Dermatology